No correlations were established between the degree of positivity of ALDH1&2 and the staging of CTNM (clinical TNM), i.e., in terms of the clinical prognosis of patients over time (clinical-pathological correlation), nor with the localization of cancers. This evidence concerns the gene ALDH1A1 and cancer.